Leflunomide-associated progressive multifocal leukoencephalopathy.
Rahmlow
Megan
M
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.
Shuster
Elizabeth A
EA
Dominik
Jacob
J
Deen
H Gordon
HG
Dickson
Dennis W
DW
Aksamit
Allen J
AJ
Robles
Hector A
HA
Freeman
William D
WD
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001706:Biopsy; D001921:Brain / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007275:Injections, Intravenous; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000077339:Leflunomide; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012640:Seizures / Q000209:etiology; D013194:Staining and Labeling
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D003561:Cytarabine; D000077339:Leflunomide